Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
In-Situ Hybridization Market Revenue Growth Supported By A CAGR Of 2.75% Through 2030
The in-situ hybridization market size has grown strongly in recent years. It will grow from $1.78 billion in 2025 to $1.94 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to expansion of molecular pathology applications, increased cancer biomarker testing, wider use of fluorescence microscopy, growth of academic genomics research, increasing adoption of ish in infectious disease studies.
The in-situ hybridization market size is expected to see strong growth in the next few years. It will grow to $2.76 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to rising demand for precision oncology diagnostics, growing integration of ai-driven image analysis, expansion of personalized medicine research, increasing investments in molecular diagnostics infrastructure, development of advanced probe technologies. Major trends in the forecast period include increasing adoption of multiplex ish techniques, rising use of automated slide scanning systems, growing demand for high-resolution spatial gene expression analysis, expansion of digital pathology integration, enhanced focus on companion diagnostics.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24571&type=smp
In-Situ Hybridization Market Expansion Supported By Key Demand Factors
The rising incidence of cancer is anticipated to fuel the growth of the in-situ hybridization market in the coming years. Cancer is a condition in which abnormal cells grow uncontrollably and can invade or spread to other body parts. Cancer cases are rising due to increasing life expectancy, as aging allows more time for genetic mutations to accumulate and for individuals to be exposed to cancer-causing factors. In-situ hybridization (ISH) plays a key role in cancer management by enabling the detection of specific genetic abnormalities within tumor cells. It is used for accurate diagnosis, prognosis, and guiding targeted therapy decisions. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, new cancer cases are projected to exceed 35 million in 2050, marking a 77% increase from the estimated 20 million cases in 2022. Therefore, the rising incidence of cancer will boost the growth of the in-situ hybridization market.
In-Situ Hybridization Market Segment Analysis: What Are The Major Market Categories?
The in-situ hybridization market covered in this report is segmented –
1) By Product: Analytical Instruments, Kits And Reagents, Software And Services, Other Products
2) By Technology: Fluorescence In Situ Hybridization, Chromogenic In Situ Hybridization, Dual-Color In Situ Hybridization
3) By Application: Cancer Diagnosis, Cytogenetics, Developmental Biology, Infectious Diseases, Immunology, Other Applications
4) By End User: Hospitals And Diagnostic Laboratories, Academic And Research Institutes, Contract Research Organizations, Pharmaceutical And Biotechnology Companies
Subsegments:
1) By Analytical Instruments: Fluorescence Microscopes, Brightfield Microscopes, Automated Slide Scanners, Hybridization Systems
2) By Kits And Reagents: DNA Probes, RNA Probes, Labeling Kits, Detection Reagents, Pretreatment Reagents
3) By Software And Services: Image Analysis Software, Data Management Software, Custom Probe Design Services, Sample Preparation Services
4) By Other Products: Slides And Coverslips, Storage Reagents, Hybridization Buffers, Control Probes
In-Situ Hybridization Market Growth Trends Influencing Competitive Dynamics
Major companies operating in the in-situ hybridization market are focusing on developing advanced solutions, such as HER2 testing solutions, to help predict patient response to targeted therapies. HER2 testing solutions are diagnostic tools used to identify the presence and level of the HER2 protein in cancer cells, helping guide targeted treatment decisions. For instance, in December 2023, Cytelabs, an India-based cancer diagnostic services provider, launched dual in situ hybridization (DISH) testing for breast cancer patients. DISH technology, approved by the US FDA, represents a significant advancement in accurate HER2 testing, which is vital for targeted breast cancer treatment. It notably decreases the waiting time by providing HER2 status results within 24 to 48 hours, helping to ease the stress experienced by patients and their families. By offering dependable results quickly, DISH allows prompt treatment planning and initiation. Since HER2 status plays a crucial role in determining prognosis and therapy, precise and efficient testing is essential for the proper evaluation of all invasive breast cancers.
In-Situ Hybridization Market Leading Companies Driving Competitive Growth
Major companies operating in the in-situ hybridization market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen NV, Bio-Techne Corporation, Leica Biosystems Nussloch GmbH, Biocare Medical LLC, BioGenex Srl, Oxford Gene Technology Inc., Creative Biolabs, Empire Genomics LLC, Abnova Corporation, BioView Ltd., Advanced Cell Diagnostics Inc., BioCat GmbH, Bio SB Inc., Genemed Biotechnologies Inc.
Access The Complete In-Situ Hybridization Market Report:
https://www.thebusinessresearchcompany.com/report/in-situ-hybridization-global-market-report
In-Situ Hybridization Market Regional Analysis And Leading Geography
North Americawas the largest region in the in-situ hybridization market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the in-situ hybridization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model